Michael Manzo's most recent trade in Kiora Pharmaceuticals Inc was a trade of 65 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on Aug. 3, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharma Inc | Michael Manzo | VP of Engineering | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share. | 03 Aug 2021 | 65 | 15,378 (0%) | 0% | 2.4 | 156 | Common Stock |
| Kiora Pharma Inc | Michael Manzo | VP of Engineering | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 02 Jul 2021 | 160 | 15,443 (0%) | 0% | 3.7 | 592 | Common Stock |
| Kiora Pharma Inc | Michael Manzo | VP of Engineering | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. | 04 Jun 2021 | 155 | 15,603 (0%) | 0% | 4.2 | 649 | Common Stock |